New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Cancer patients treated with immunotherapy can safely receive mRNA COVID-19 vaccines

Cancer patients treated with immunotherapy can safely receive mRNA COVID-19 vaccines

by National Comprehensive Cancer NetworkSwimmer’s plot depicting days from first dose of mRNA SARS-CoV-2 vaccine to irAEs among patients who received an ICI within 90 days before or after vaccination
Public Health & Prevention December 26,2023
Cancer patients treated with immunotherapy can safely receive mRNA COVID-19 vaccines

Cancer patients treated with immunotherapy can safely receive mRNA COVID-19 vaccines

by National Comprehensive Cancer NetworkSwimmer’s plot depicting days from first dose of mRNA SARS-CoV-2 vaccine to irAEs among patients who received an ICI within 90 days before or after vaccination
Public Health & Prevention December 26,2023
Lower prostate cancer screening rates associated with subsequent increase in advanced cancers

Lower prostate cancer screening rates associated with subsequent increase in advanced cancers

byAmerican Society for Radiation OncologyProstate cancer cells. Credit: NIH Image GalleryIn the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings, a
Oncology December 26,2023
Lower prostate cancer screening rates associated with subsequent increase in advanced cancers

Lower prostate cancer screening rates associated with subsequent increase in advanced cancers

byAmerican Society for Radiation OncologyProstate cancer cells. Credit: NIH Image GalleryIn the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings, a
Oncology December 26,2023
New insights into how blood pressure drug may benefit patients with locally advanced pancreatic cancer

New insights into how blood pressure drug may benefit patients with locally advanced pancreatic cancer

byMassachusetts General HospitalCredit: Unsplash/CC0 Public DomainPancreatic cancer is highly lethal, and surgical removal of tumor tissue is currently the only potential cure for most patients.
Oncology December 26,2023
New insights into how blood pressure drug may benefit patients with locally advanced pancreatic cancer

New insights into how blood pressure drug may benefit patients with locally advanced pancreatic cancer

byMassachusetts General HospitalCredit: Unsplash/CC0 Public DomainPancreatic cancer is highly lethal, and surgical removal of tumor tissue is currently the only potential cure for most patients.
Oncology December 26,2023
Blood pressure drug may prevent immunotherapy-induced brain swelling in patients with glioblastoma

Blood pressure drug may prevent immunotherapy-induced brain swelling in patients with glioblastoma

byMassachusetts General HospitalICB increases GBM vascular leakage and induces brain edema. MR T2-weighted-Fluid-Attenuated Inversion Recovery (T2-FLAIR) images obtained from a recurrent GBM pat
Oncology December 26,2023
Blood pressure drug may prevent immunotherapy-induced brain swelling in patients with glioblastoma

Blood pressure drug may prevent immunotherapy-induced brain swelling in patients with glioblastoma

byMassachusetts General HospitalICB increases GBM vascular leakage and induces brain edema. MR T2-weighted-Fluid-Attenuated Inversion Recovery (T2-FLAIR) images obtained from a recurrent GBM pat
Oncology December 26,2023
Integrating mental health services into oncology treatment protocols

Integrating mental health services into oncology treatment protocols

byThe City University of New YorkStudy participant is interviewed. Credit: The City University of New YorkA new study by CUNY SPH doctoral student Thinh Vu and colleagues reveals that cancer inp
Oncology December 26,2023
Integrating mental health services into oncology treatment protocols

Integrating mental health services into oncology treatment protocols

byThe City University of New YorkStudy participant is interviewed. Credit: The City University of New YorkA new study by CUNY SPH doctoral student Thinh Vu and colleagues reveals that cancer inp
Oncology December 26,2023
Concentration of surgical care to one research hospital shown to improve operations for childhood cancer

Concentration of surgical care to one research hospital shown to improve operations for childhood cancer

by Princess Máxima Center for Pediatric OncologyEstimated event-free survival (EFS) for neuroblastoma provided by Kaplan Meier's methodology (log rank 0.260). Credit: European Journal of Surgical
Oncology December 26,2023
Concentration of surgical care to one research hospital shown to improve operations for childhood cancer

Concentration of surgical care to one research hospital shown to improve operations for childhood cancer

by Princess Máxima Center for Pediatric OncologyEstimated event-free survival (EFS) for neuroblastoma provided by Kaplan Meier's methodology (log rank 0.260). Credit: European Journal of Surgical
Oncology December 26,2023
Bringing crucial cancer treatments to rural communities

Bringing crucial cancer treatments to rural communities

by Velvet Hasner,Missouri University of Science and TechnologyCredit: Pexels image by Peter FazekasFresh air, sunsets, and a night sky full of stars are a few of the benefits to country living t
Oncology December 26,2023
Bringing crucial cancer treatments to rural communities

Bringing crucial cancer treatments to rural communities

by Velvet Hasner,Missouri University of Science and TechnologyCredit: Pexels image by Peter FazekasFresh air, sunsets, and a night sky full of stars are a few of the benefits to country living t
Oncology December 26,2023
Reprogramming cancer cells into immune defenders

Reprogramming cancer cells into immune defenders

by Tove Smeds,Lund UniversityDolly the sheep determined Filipe Pereira’s future career. The choice was between becoming an architect or a scientist, when one of the world’s most extreme examples
Oncology December 26,2023
Reprogramming cancer cells into immune defenders

Reprogramming cancer cells into immune defenders

by Tove Smeds,Lund UniversityDolly the sheep determined Filipe Pereira’s future career. The choice was between becoming an architect or a scientist, when one of the world’s most extreme examples
Oncology December 26,2023
Exposing cancers to bacteria reminds first responder immune cells which side they're on

Exposing cancers to bacteria reminds first responder immune cells which side they're on

byGarvan InstituteCancer cells (green) being attacked by neutrophils (red) in the collagen structure (blue) of a tumour’s microenvironment. Credit: Jacqueline Bailey / Dr Chtanova's Innate T
Oncology December 26,2023
Exposing cancers to bacteria reminds first responder immune cells which side they're on

Exposing cancers to bacteria reminds first responder immune cells which side they're on

byGarvan InstituteCancer cells (green) being attacked by neutrophils (red) in the collagen structure (blue) of a tumour’s microenvironment. Credit: Jacqueline Bailey / Dr Chtanova's Innate T
Oncology December 26,2023
Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th
Oncology December 26,2023
Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th
Oncology December 26,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com